Company
NetherlandsLonza Netherlands B.V., Netherlands – FDA Inspections
Inspection records and compliance data for Lonza Netherlands B.V.. 1 FDA inspection on record, 1 Form 483, last inspected July 12, 2024.
Company Profile
This profile covers Lonza Netherlands B.V. based in Netherlands.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected July 12, 2024.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 12, 2024 | Not classified | Biologics | 1246026 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Octapharma AB
GC Biopharma Corp_Ochang Plant
GlaxoSmithKline Vaccines Srl
AstraZeneca Pharmaceuticals LP
Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
LifeSouth Community Blood Centers, Inc
Duke Medical Center-Carolinas Cord Blood Bank and Stem Cell Laboratory
FUJIFILM Diosynth Biotechnologies California, Inc.
Wyeth Farma SA
Baxalta Belgium Manufacturing SA
Company Information
Name
Lonza Netherlands B.V.
FEI Number
3014382532
Address
Netherlands
Country
Netherlands
ID: f39deee8-be7f-41a8-b12e-d2cf810de4c1